OverviewSuggest Edit

    NeuroNascent is a company that focuses on generating new neurons reversing neurological disorders. It discovers oral therapies supporting neuron regeneration in order to reverse chronic neurological diseases and aging progression.

    Latest Updates

    Employees (est.) (Apr 2020)7(+134%)
    Cybersecurity ratingBMore

    Key People/Management at NeuroNascent

    Judith Kelleher-Andersson

    Judith Kelleher-Andersson

    President and Chief Executive Officer (CEO), Director
    Kenneth Narducy

    Kenneth Narducy

    Acting COO, Director
    Show more

    NeuroNascent Financials and Metrics

    Summary Metrics

    Founding Date


    NeuroNascent latest funding size

    $1.20 m

    NeuroNascent investors

    Show all financial metrics

    NeuroNascent Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    NeuroNascent Online and Social Media Presence

    Embed Graph

    NeuroNascent Frequently Asked Questions

    • When was NeuroNascent founded?

      NeuroNascent was founded in 2004.

    • Who are NeuroNascent key executives?

      NeuroNascent's key executives are Judith Kelleher-Andersson and Kenneth Narducy.

    • How many employees does NeuroNascent have?

      NeuroNascent has 7 employees.

    • Who are NeuroNascent competitors?

      Competitors of NeuroNascent include Phi Therapeutics, Siolta Therapeutics and Cord Blood Registry.